Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence (Q35166683)

6 August 2017

1 reference

title

Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence (English)

1 reference

6 August 2017

1 reference

David Rp Guay

1

1 reference

6 August 2017

publication date

1 June 2005

1 reference

Therapeutics and Clinical Risk Management

6 August 2017

published in

1 reference

6 August 2017

volume

1

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

157-167

1 reference

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Clinical Pharmacokinetics of Drugs Used to Treat Urge Incontinence

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Effects of two anticholinergic drugs, trospium chloride and biperiden, on motility and evoked potentials of the oesophagus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Effect of the quaternary ammonium compound trospium chloride on 24 hour jejunal motility in healthy subjects

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Ultrasound studies of the effect of trospium chloride on gall-bladder kinetics

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1661617

Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial

27 September 2018

1 reference

https://api.crossref.org/works/10.2147%2FTCRM.1.2.157.62912

Inappropriate rise in heart rate caused by intravenous administration of trospium chloride during upper gastrointestinal endoscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FTCRM.1.2.157.62912

The use of a compact protable microcomputer system (EPSON HX 20) to measure on-line the contractile activity of the digestive tract from eight channels. Application to pharmacological tests

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FTCRM.1.2.157.62912

Trospium chloride for the treatment of detrusor instability in children

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FTCRM.1.2.157.62912

Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FTCRM.1.2.157.62912

Effect of trospium chloride on gastrointestinal motility in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FTCRM.1.2.157.62912

Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FTCRM.1.2.157.62912

Lipophilisation of hydrophilic compounds. Consequences on transepidermal and intestinal transport of trospium chloride

31 March 2020

1 reference

12 December 2020

Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle

1 reference

12 December 2020

Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder

1 reference

12 December 2020

Heart rate increase after intravenous administration of trospium chloride and scopolamine during endoscopic retrograde cholangiopancreatography

1 reference

12 December 2020

Safety and tolerance of trospium chloride in the high dose range

1 reference

12 December 2020

10.2147/TCRM.1.2.157.62912

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference